The Gordon Wilson Lecture. The Mayo model: one path to an academic medical center.

por Weinshilboum, Richard M.
Publicado em 2002

SLC6A4 Variation and Citalopram Response

por Weinshilboum, Richard M.
Publicado em 2009

Pharmacogenomics: candidate gene identification, functional validation and mechanisms

por Wang, Liewei, Weinshilboum, Richard M.
Publicado em 2008

Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity

por Weinshilboum, Richard M., Sladek, Susan L.
Publicado em 1980

Cardiovascular pharmacogenomics and individualized drug therapy

por Pereira, Naveen L., Weinshilboum, Richard M.
Publicado em 2009

Immune Mediator Pharmacogenomics: TCL1A SNPs and Estrogen-Dependent Regulation of Inflammation

por Ho, Ming-Fen, Weinshilboum, Richard M.
Publicado no J Nat Sci (2017)

Catechol O-MethyItransferase Pharmacogenomics: Challenges, and Opportunities

por Ho, Ming-Fen, Weinshilboum, Richard M.
Publicado no Clin Pharmacol Ther (2019)

Inheritance of Low Serum Immunoglobulin D

por Dunnette, Sandra L., Gleich, Gerald J., Weinshilboum, Richard M.
Publicado em 1978

Genomics and Drug Response

por Wang, Liewei, McLeod, Howard L., Weinshilboum, Richard M.
Publicado em 2011

Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation

por Li, Fang, Wang, Liewei, Burgess, Rebecca J., Weinshilboum, Richard M.
Publicado em 2008

The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases

por Neavin, Drew R., Liu, Duan, Ray, Balmiki, Weinshilboum, Richard M.
Publicado no Int J Mol Sci (2018)

Two-Phase Designs to Follow-Up Genome-Wide Association Signals With DNA Resequencing Studies

por Schaid, Daniel J., Jenkins, Gregory D., Ingle, James N., Weinshilboum, Richard M.
Publicado em 2013

Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women

por Moyer, Ann M., de Andrade, Mariza, Weinshilboum, Richard M., Miller, Virginia M.
Publicado no Menopause (2016)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine

por Ho, Ming-Fen, Zhang, Cheng, Zhang, Lingxin, Li, Hu, Weinshilboum, Richard M.
Publicado no Front Pharmacol (2019)

PharmGKB summary - very important pharmacogene information for GSTT1

por Thorn, Caroline F., Ji, Yuan, Weinshilboum, Richard M., Altman, Russ B., Klein, Teri E.
Publicado em 2012

Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction

por Liu, Duan, Qin, Sisi, Ray, Bamiki, Kalari, Krishna R., Wang, Liewei, Weinshilboum, Richard M.
Publicado no Drug Metab Dispos (2018)

The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness

por Monte, Andrew A., Heard, Kennon J., Campbell, Jenny, Hamamura, D., Weinshilboum, Richard M., Vasiliou, Vasilis
Publicado em 2014

Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers

por Li, Liang, Fridley, Brooke L., Kalari, Krishna, Jenkins, Gregory, Batzler, Anthony, Weinshilboum, Richard M., Wang, Liewei
Publicado em 2009

Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen

por Wu, Tse-Yu, Fridley, Brooke L., Jenkins, Gregory D., Batzler, Anthony, Wang, Liewei, Weinshilboum, Richard M.
Publicado em 2011

Pharmacogenomics and Patient Care: One Size Does Not Fit All

por Giacomini, Kathleen M., Yee, Sook Wah, Ratain, Mark J., Weinshilboum, Richard M., Kamatani, Naoyuki, Nakamura, Yusuke
Publicado em 2012